Khalil Fouad, Asleh Rabea, Perue Radha Kanneganti, Weinstein Jean-Marc, Solomon Adam, Betesh-Abay Batya, Briasoulis Alexandros, Alnsasra Hilmi
Department of Internal Medicine, University of South Dakota, Sioux Falls, SD 57105, USA.
Heart Institute, Hadassah University Medical Center, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem P.O. Box 12000, Israel.
Biomedicines. 2023 Mar 2;11(3):757. doi: 10.3390/biomedicines11030757.
Left ventricular assist devices (LVADs) have been increasingly used in patients with advanced heart failure, either as a destination therapy or as a bridge to heart transplant. Continuous flow (CF) LVADs have revolutionized advanced heart failure treatment. However, significant vascular pathology and complications have been linked to their use. While the newer CF-LVAD generations have led to a reduction in some vascular complications such as stroke, no major improvement was noticed in the rate of other vascular complications such as gastrointestinal bleeding. This review attempts to provide a comprehensive summary of the effects of CF-LVAD on vasculature, including pathophysiology, clinical implications, and future directions.
左心室辅助装置(LVADs)已越来越多地用于晚期心力衰竭患者,作为终末期治疗或心脏移植的过渡治疗。连续血流(CF)左心室辅助装置彻底改变了晚期心力衰竭的治疗方式。然而,显著的血管病变和并发症与它们的使用有关。虽然新一代的CF-LVAD已使某些血管并发症(如中风)的发生率有所降低,但在其他血管并发症(如胃肠道出血)的发生率方面未观察到重大改善。本综述试图全面总结CF-LVAD对脉管系统的影响,包括病理生理学、临床意义和未来方向。